Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Hemmorex-HC

CompanyLaser Pharmaceuticals, LLC (DUNS: 614417132)

Effective Date

July 16, 2021

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Hydrocortisone acetate(25 mg in 1 1)

Products (1)

Hemmorex-HC

NDC Product Code

16477-201

Route of Administration

RECTAL

Effective Date

July 16, 2021

Ingredients

Hydrocortisone acetateActive

Code: 3X7931PO74Class: ACTIBQuantity: 25 mg in 1 1

HYDROGENATED PALM KERNEL OILInactive

Code: FM8D1RE2VPClass: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy